DOCSLIB.ORG

Supplemental Table 1. Overview of the Organisms Isolated by Blood

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Supplemental Table 1. Overview of the Organisms Isolated by Blood Supplemental Table 1. Overview of the organisms isolated by blood culture N of deaths in children with N of multidrug- multidrug- N of infections N of patients (% resistant resistant Organism (% of total) of total) N of deaths infections (%) infections Coagulase negative staphylococcus (CNS) 62 (15.0) 61 (18.9) 19 Staphylococcus aureus 61 (14.8) 60 (18.6) 9 8 (13.1) 0 Enterobacter cloacae 30 (7.3) 30 (7.3) 7 15 (50.0) 4 Escherichia coli 24 (5.8) 24 (7.4) 8 2 (8.3) 0 Pseudomonas aeruginosa 23 (5.6) 23 (7.1) 9 6 (26.1) 3 Streptococcus spp. 22 (5.3) 17 (5.3) 3 Klebsiella pneumoniae 20 (4.9) 20 (6.2) 8 5 (25.0) 3 Candida albicans 18 (4.4) 18 (5.6) 7 Enterococcus faecalis 17 (4.1) 17 (5.3) 7 Klebsiella oxytoca 13 (3.2) 13 (4.0) 3 2 (15.4) 1 Serratia spp. 10 (2.4) 10 (3.1) 1 2 (20.0) 0 Streptococcus pneumoniae 10 (2.4) 10 (3.1) 0 Other Candida spp. 10 (2.4) 9 (2.8) 3 Acinetobacter baumannii complex 8 (1.9) 8 (2.5) 2 6 1 Haemophilus influenzae (not type b) 7 (1.7) 7 (2.2) 1 Other Enterococcus spp. 6 (1.5) 6 (1.9) 3 2 1 Other Fungi 5 (1.2) 5 (1.5) 3 Alpha haemolytic Streptococcus 5 (1.2) 5 (1.5) 1 Beta haemolytic streptococcus 5 (1.2) 5 (1.5) 0 Neisseria spp. 5 (1.2) 5 (1.5) 0 Bacillus cereus 5 (1.2) 5 (1.5) 0 Other Enterobacter spp. 4 4 2 1 1 Pantoea spp. 4 4 1 2 1 Stenotrophomonas maltophilia 4 4 0 Burkholderia cepacia complex 3 3 2 Other Acinetobacter spp. 3 3 1 1 0 Gram positive bacilli 3 3 1 Lactobacillus spp. 3 3 1 Rothia dentocariosa 2 2 1 Stomatococcus mucilaginosus 2 2 1 Aspergillus spp. 1 1 1 Flavimonas oryzihabitans 1 1 1 Gram negative bacilli 1 1 1 Massilia spp. 1 1 1 Raoultella ornithinolytica 1 1 1 Wautersia paucula 1 1 1 Aeromonas sobria 1 1 0 Brevundimonas vesicularis 1 1 0 Citrobacter freundii 1 1 0 Clostridium perfringens 1 1 0 Dermabacter hominis 1 1 0 Granulicatella adiacens 1 1 0 Other haemophilus spp. 1 1 0 Kocuria rosea 1 1 0 Leuconostoc spp. 1 1 0 Proteus mirabilis 1 1 0 Other Pseudomonas spp. 1 1 0 Sphingomonas paucimobilis 1 1 0 Total BLCU results 412 52 Total patients 323 86 14 Supplemental Table 2. Overview of the organisms isolated by BAL N of deaths in children with N of multidrug- multidrug- N of infections N of patients (% resistant resistant Organism (% of total) of total) N of deaths infections (%) infections Staphylococcus aureus 247 (21.7) 240 (35.7) 28 10 (4.0) 2 Haemophilus influenzae (not type b) 141 (12.4) 139 (20.7) 7 Moraxella catarrhalis 112 (9.9) 108 (16.1) 8 Candida albicans 105 (9.2) 104 (15.5) 21 Pseudomonas aeruginosa 78 (6.9) 69 (10.3) 12 9 (11.5) 1 Enterobacter cloacae 65 (5.7) 64 (9.5) 13 16 (24.6) 1 Streptococcus pneumoniae 61 (5.4) 60 (8.9) 1 Escherichia coli 44 (3.9) 42 (6.3) 10 4 (9.1) 1 Klebsiella pneumoniae 38 (3.3) 38 (5.7) 8 5 (13.2) 3 Other Candida spp. 31 (2.7) 25 (3.7) 8 Acinetobacter baumanii complex 27 (2.4) 27 (4.0) 6 19 (70.4) 5 Klebsiella oxytoca 24 (2.1) 24 (3.6) 8 5 (20.8) 1 Stenotrophomonas maltophilia 22 (1.9) 22 (3.3) 5 2 (9.1) 1 Aspergillus spp. 19 (1.7) 19 (2.8) 5 Serratia spp. 17 (1.5) 16 (2.4) 3 Enterococcus faecalis 16 (1.4) 16 (2.4) 7 Other Haemophilus spp. 13 (1.1) 13 (1.9) 3 1(7.7) 0 Beta haemolytic Streptococcus 12 (1.1) 12 (1.8) 1 Other Enterobacter spp. 9 9 (1.3) 5 3 2 Gram negative bacilli 6 6 0 Proteus mirabilis 5 5 3 Burholderica cepacia complex 5 5 3 2 1 Other Streptococcus spp. 3 3 1 Aeromonas spp. 3 3 0 Other Fungi 3 3 0 Coagulase Negative Staphylococcus (CNS) 2 2 2 Chryseobacterium meningosepticum 2 2 1 1 1 Raoultella spp. 2 2 1 Other Acinetobacter spp. 2 2 1 2 1 Citrobacter spp. 2 2 0 1 0 Neisseria spp. 2 2 0 Achromobacter xylosoxidans 1 1 1 1 1 Chryseomonas indologenes 1 1 1 Elizabethkingia meningoseptica 1 1 1 1 1 Sphingomonas paucimobilis 1 1 1 1 1 Eikenella corrodens 1 1 0 Hafnia alvei 1 1 0 Pantoea spp. 1 1 0 Other Pseudomonas spp. 1 1 0 Ralstonia pickettii 1 1 0 Rhodococcus spp. 1 1 0 Total BAL results 1137 83 Total patients 672 100 18 Supplemental Table 3. Bacteraemia and pneumonia rates per 1000 admissions in PICU from 2002 to 2012. Total infection rate Gram negative Gram positive Fungal infection Year [95% CI] infection rate [95% CI] infection rate [95% CI] rate [95% CI] 2002 74.9 (61.6-90.1) 31.7 (23.1-42.3) 36.0 (26.9-47.2) 7.2 (3.5-13.2) 2003 87.5 (73.1-103.6) 43.4 (33.3-55.5) 30.4 (22.0-40.8) 13.7 (8.3-21.4) 2004 103.5 (88.3-120.2) 53.8 (42.8-66.6) 36.8 (27.7-47.7) 12.9 (7.8-20.1) 2005 99.9 (84.8-116.6) 50.6 (39.8-63.3) 41.5 (31.7-53.2) 7.7 (3.9-13.8) 2006 109.8 (94.3-127.0) 57.3 (46.0-70.5) 43.0 (33.2-54.7) 9.5 (5.2-16.0) 2007 113.0 (96.2-131.5) 61.1 (48.7-75.6) 41.8 (31.6-54.2) 10.1 (5.4-17.1) 2008 112.6 (95.3-131.9) 47.5 (36.2-61.2) 46.7 (35.5-60.2) 18.3 (11.5-27.6) 2009 117.8 (100.6-136.8) 65.2 (52.3-80.2) 33.0 (23.9-44.3) 19.6 (12.7-28.9) 2010 116.9 (100.2-135.2) 63.6 (51.2-78.0) 37.0 (27.6-48.5) 16.3 (10.2-24.5) 2011 69.1 (56.2-83.9) 41.9 (31.9-54.0) 18.4 (11.9-27.0) 8.8 (4.6-15.4) 2012 84.1 (70.0-99.9) 42.4 (32.4-54.3) 27.3 (19.4-37.3) 14.4 (8.8-22.1) Supplemental Table 4. Multidrug-resistant infection rates per 1000 admissions in PICU from 2002 until 2012. Total multidrug-resistant ESBL producing infection rate Year infection rate (95% CI) (95% CI) 2002 7.2 (3.5-13.2) 6.5 (3.0-12.2) 2003 6.5 (3.0-12.3) 5.8 (2.5-11.7) 2004 9.5 (5.2-15.9) 8.8 (4.7-15.1) 2005 6.3 (2.9-12.0) 4.2 (1.6-9.2) 2006 6.1 (2.8-11.6) 4.1 (1.5-8.9) 2007 7.7 (3.7-14.2) 7.0 (3.2-13.2) 2008 9.2 (4.6-16.4) 5.0 (1.8-10.9) 2009 11.0 (6.0-18.4) 9.4 (4.9-16.4) 2010 16.3 (10.2-24.5) 14.8 (9.1-22.8) 2011 8.1 (4.0-14.4) 6.6 (3.0-12.5) 2012 7.2 (3.5-13.2) 6.5 (3.0-12.2) Supplemental Table 5. Bacteraemia rates per 1000 admissions in PICU from 2002 to 2012 Total infection rate Gram negative Gram positive Fungal infection Year [95% CI] infection rate [95% CI] infection rate [95% CI] rate [95% CI] 2002 46.8 (36.3-59.3) 9.3 (5.0-16.0) 36.0 (26.9-47.2) 1.4 (0.2-5.2) 2003 47.0 (36.5-59.5) 11.6 (6.6-18.7) 34.0 (25.1-44.9) 1.4 (0.2-5.2) 2004 53.1 (42.2-65.8) 12.9 (7.8-20.1) 34.7 (26.0-45.4) 4.8 (1.9-9.8) 2005 54.1 (43.0-67.2) 14.8 (9.1-22.5) 38.0 (28.7-49.3) 1.4 (0.2-5.1) 2006 53.2 (42.3-66.0) 10.2 (5.7-16.8) 42.3 (32.6-53.9) 0.6 (0.0-3.8) 2007 48.8 (37.7-62.0) 8.5 (4.3-15.2) 39.5 (29.5-51.6) 0.8 (0.0-4.3) 2008 45.9 (34.7-59.3) 10.8 (5.8-18.5) 30.9 (21.8-42.3) 4.2 (1.4-9.7) 2009 52.6 (41.0-66.4) 8.6 (4.3-15.4) 40.8 (30.6-53.2) 3.1 (0.9-8.0) 2010 45.1 (34.7-57.6) 17.8 (11.4-26.3) 25.1 (17.5-35.0) 2.2 (0.4-6.5) 2011 37.5 (28.0-49.0) 9.6 (5.1-16.3) 26.5 (18.6-36.5) 1.5 (0.2-5.3) 2012 42.4 (32.4-54.3) 10.1 (5.5-16.8) 29.5 (21.2-39.7) 2.9 (0.8-7.3) Supplemental Table 6.
Load more

Recommended publications
  • Helicobacter Pylori Infection and Its Potential Association with Idiopathic
    Journal of Immunology and Infectious Diseases Volume 2 | Issue 2 ISSN: 2394-6512 Research Article Open Access Helicobacter pylori Infection and its Potential Association with Idiopathic Hypercalciuric Urolithiasis in Pediatric Patients Ali AM*1, Abdelaziz SS2 and Elkhatib WF3,4 1Department of Pediatrics, International Islamic Center for Population Studies and Research, Faculty of Medicine, Al-Azhar University, Cairo, Egypt 2Department of Urology, Faculty of Medicine, Al-Azhar University, Cairo, Egypt 3Department of Microbiology & Immunology, Faculty of Pharmacy, Ain Shams University, African Union Organization St. Abbassia, Cairo, Egypt 4Department of Pharmacy Practice, School of Pharmacy, Hampton University, Kittrell Hall Hampton, Virginia, USA *Corresponding author: Ali AM, Department of Pediatrics, Faculty of Medicine, Al-Azhar University, Cairo, Egypt, Postal Code: 31991, Dr. Noor Mohammad Khan General Hospital, Fax: +966713221417, Tel: +966556847829, E-mail: [email protected] Citation: Ali AM, Abdelaziz SS, Elkhatib WF (2014) Helicobacter pylori Infection and its Potential Association with Idiopathic Hypercalciuric Urolithiasis in Pediatric Patients. J Immunol Infect Dis 2(2): 202. doi: 10.15744/2394-6512.1.203 Received Date: September 24, 2014 Accepted Date: January 05, 2015 Published Date: January 09, 2015 Abstract Objectives: To evaluate the role of Helicobacter pylori infection in the pathogenesis of idiopathic hypercalciuric urolithiasis. Design & Setting: Randomized longitudinal controlled study was carried out at Al-Azhar University Hospitals in Cairo and Dommiat, Egypt as well as at Noor Khan General Hospital in Hafer Al-Baten, Saudi Arabia. Participants: A total of 150 patients categorized into 100 cases (urolithiasis-positive) with urinary stone disease, aged from 5 to 18 years, and met the characteristics of idiopathic urolithiasis in children as well as 50 controls (urolithiasis-negative) that had relatively similar demographic criteria except for idiopathic urolithiasis.
    [Show full text]
  • Uncommon Pathogens Causing Hospital-Acquired Infections in Postoperative Cardiac Surgical Patients
    Published online: 2020-03-06 THIEME Review Article 89 Uncommon Pathogens Causing Hospital-Acquired Infections in Postoperative Cardiac Surgical Patients Manoj Kumar Sahu1 Netto George2 Neha Rastogi2 Chalatti Bipin1 Sarvesh Pal Singh1 1Department of Cardiothoracic and Vascular Surgery, CN Centre, All Address for correspondence Manoj K Sahu, MD, DNB, Department India Institute of Medical Sciences, Ansari Nagar, New Delhi, India of Cardiothoracic and Vascular Surgery, CTVS office, 7th floor, CN 2Infectious Disease, Department of Medicine, All India Institute of Centre, All India Institute of Medical Sciences, New Delhi-110029, Medical Sciences, Ansari Nagar, New Delhi, India India (e-mail: [email protected]). J Card Crit Care 2020;3:89–96 Abstract Bacterial infections are common causes of sepsis in the intensive care units. However, usually a finite number of Gram-negative bacteria cause sepsis (mostly according to the hospital flora). Some organisms such as Escherichia coli, Acinetobacter baumannii, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Staphylococcus aureus are relatively common. Others such as Stenotrophomonas maltophilia, Chryseobacterium indologenes, Shewanella putrefaciens, Ralstonia pickettii, Providencia, Morganella species, Nocardia, Elizabethkingia, Proteus, and Burkholderia are rare but of immense importance to public health, in view of the high mortality rates these are associated with. Being aware of these organisms, as the cause of hospital-acquired infections, helps in the prevention, Keywords treatment, and control of sepsis in the high-risk cardiac surgical patients including in ► uncommon pathogens heart transplants. Therefore, a basic understanding of when to suspect these organ- ► hospital-acquired isms is important for clinical diagnosis and initiating therapeutic options. This review infection discusses some rarely appearing pathogens in our intensive care unit with respect to ► cardiac surgical the spectrum of infections, and various antibiotics that were effective in managing intensive care unit these bacteria.
    [Show full text]
  • Antibiotic Use Guidelines for Companion Animal Practice (2Nd Edition) Iii
    ii Antibiotic Use Guidelines for Companion Animal Practice (2nd edition) iii Antibiotic Use Guidelines for Companion Animal Practice, 2nd edition Publisher: Companion Animal Group, Danish Veterinary Association, Peter Bangs Vej 30, 2000 Frederiksberg Authors of the guidelines: Lisbeth Rem Jessen (University of Copenhagen) Peter Damborg (University of Copenhagen) Anette Spohr (Evidensia Faxe Animal Hospital) Sandra Goericke-Pesch (University of Veterinary Medicine, Hannover) Rebecca Langhorn (University of Copenhagen) Geoffrey Houser (University of Copenhagen) Jakob Willesen (University of Copenhagen) Mette Schjærff (University of Copenhagen) Thomas Eriksen (University of Copenhagen) Tina Møller Sørensen (University of Copenhagen) Vibeke Frøkjær Jensen (DTU-VET) Flemming Obling (Greve) Luca Guardabassi (University of Copenhagen) Reproduction of extracts from these guidelines is only permitted in accordance with the agreement between the Ministry of Education and Copy-Dan. Danish copyright law restricts all other use without written permission of the publisher. Exception is granted for short excerpts for review purposes. iv Foreword The first edition of the Antibiotic Use Guidelines for Companion Animal Practice was published in autumn of 2012. The aim of the guidelines was to prevent increased antibiotic resistance. A questionnaire circulated to Danish veterinarians in 2015 (Jessen et al., DVT 10, 2016) indicated that the guidelines were well received, and particularly that active users had followed the recommendations. Despite a positive reception and the results of this survey, the actual quantity of antibiotics used is probably a better indicator of the effect of the first guidelines. Chapter two of these updated guidelines therefore details the pattern of developments in antibiotic use, as reported in DANMAP 2016 (www.danmap.org).
    [Show full text]
  • Investigating the Biological and Mechanical Performance of Cranberry-Modified Silicone Materials for Use in Implantable Medical Devices
    Investigating the biological and mechanical performance of cranberry-modified silicone materials for use in implantable medical devices By Louis Briggs Department of Chemical Engineering McGill University, Montreal August 2014 A thesis submitted to McGill University in partial fulfillment of the requirements of the degree of Master of Engineering © Louis Briggs 2014 Abstract Catheter associated urinary tract infections (CAUTIs) are the second most common type of hospital acquired infection in North America with over a million cases reported each year. This high incidence rate, together with the dissemination of antibiotic resistant uropathogens has resulted in much interest in the development of preventative measures within the research community. The consumption of Vaccinium macrocarpon, the North American cranberry, has been linked with the prevention of bacterial infections in the urinary tract for over 100 years. The McGill Biocolloids and Surfaces Laboratory has shown that cranberry derived materials (CDMs) can inhibit bacterial adherence to surfaces, impair bacterial motility, and influence various bacterial virulence functions. It is therefore hypothesized that cranberries and CDMs could prevent the development of CAUTIs via the disruption of various stages of pathogenesis. Herein, we report on the bioperformance of cranberry impregnated biomedical grade silicone against the biofilms formed by Proteus mirabilis, a clinically relevant uropathogen. In addition, the mechanical performance of this cranberry-silicone hybrid material is studied. First, the release of bioactive cranberry materials into an aqueous environment is demonstrated in lysogeny broth using a spectrophotometric method. Second, the ultimate tensile strength, elongation at break, storage modulus, and contact angle of CDM impregnated silicone are reported. Finally, the ability of P.
    [Show full text]
  • Pdf 355.26 K
    Beni-Suef BS. VET. MED. J. JULY 2010 VOL.20 NO.2 P.16-24 Veterinary Medical Journal An approach towards bacterial pathogens of zoonotic importance harbored by commensal rodents prevalent in Beni- Suef Governorate W. H. Hassan1, A. E. Abdel-Ghany2 1Department of Bacteriology, Mycology and Immunology, and 2 Department of Hygiene, Management and Zoonoses, Faculty of Veterinary Medicine, Beni-Suef University, Beni-Suef, Egypt This study was conducted in the period July 2009 through June 2010 to determine the role of commensal rodents in transmitting bacterial pathogens to man in Beni-Suef Governorate, Egypt. A total of 50 rats of various species were selected from both urban and rural areas at different localities. In the laboratory, rodent species were identified and bacteriological examination was performed. Seven types of samples were cultured from external and internal body parts of each rat. The identified rodent spp. included Rattus norvegicus (16%), Rattus rattus rattus (42%) and Rattus rattus frugivorus (42%). The results demonstrated that S. aureus, S. lentus, S. sciuri and S. xylosus were isolated from the examined rats at percentages of 8, 2, 6 and 6 %, respectively. Moreover, E. durans (2%), E. faecalis (12%), E. faecium (24%), E. gallinarum (4%), Aerococcus viridans (12%) and S. porcinus (2%) in addition to Lc. lactis lactis (4%), Leuconostoc sp. (2%) and Corynebacterium kutscheri (8%) were also harbored by the screened rodents. On the other hand, S. arizonae, E. coli, E. cloacae and E. sakazakii were isolated from the examined rats at percentages of 4, 8, 4 and 6 %, respectively. Besides, Proteus mirabilis (6%), Proteus vulgaris (2%), Providencia rettgeri (6%), P.
    [Show full text]
  • Worldwide Links Between Proteus Mirabilis and Rheumatoid Arthritis
    al of Arth rn ri u ti o s J Journal of Arthritis Wilson et al., J Arthritis 2015, 4:1 10.4172/2167-7921.1000142 ISSN: 2167-7921 DOI: Review Open access Worldwide Links between Proteus mirabilis and Rheumatoid Arthritis Clyde Wilson1*, Taha Rashid2 and Alan Ebringer2 1Department of Pathology, King Edward VII Memorial Hospital, Paget DV 07, Bermuda 2Analytical Sciences Group, King’s College London, Stamford Road, London SE1 9NN, UK *Corresponding author: Dr. Clyde Wilson, Department of Pathology, King Edward VII Memorial Hospital, Paget DV 07, Bermuda, USA, Tel: +1-4412391011; Fax: +1-4412392193; Email: [email protected] Rec date: November 26, 2014; Acc date: January 9, 2015; Pub date: January 15, 2015 Copyright: © 2015 Wilson C, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Abstract Rheumatoid arthritis (RA) is a systemic and arthritic autoimmune disease affecting millions of people throughout the world. During the last 4 decades extensive data indicate that subclinical urinary tract infection by Proteus mirabilis has a role in the aetiopathogenesis of RA based on cross-reactivity or molecular mimicry between Proteus haemolysin and RA-associated HLA-DRB1 alleles as well as between Proteus urease and type XI collagen. Studies from 15 countries have shown that antibodies against Proteus microbes were elevated significantly in patients with active RA in comparison to healthy and non-RA disease controls. Proteus microbes could also be isolated more frequently in the urine of patients with RA than in controls.
    [Show full text]
  • Carbapenem-Resistant Enterobacteriaceae a Microbiological Overview of (CRE) Carbapenem-Resistant Enterobacteriaceae
    PREVENTION IN ACTION MY bugaboo Carbapenem-resistant Enterobacteriaceae A microbiological overview of (CRE) carbapenem-resistant Enterobacteriaceae. by Irena KennelEy, PhD, aPRN-BC, CIC This agar culture plate grew colonies of Enterobacter cloacae that were both characteristically rough and smooth in appearance. PHOTO COURTESY of CDC. GREETINGS, FELLOW INFECTION PREVENTIONISTS! THE SCIENCE OF infectious diseases involves hundreds of bac- (the “bug parade”). Too much information makes it difficult to teria, viruses, fungi, and protozoa. The amount of information tease out what is important and directly applicable to practice. available about microbial organisms poses a special problem This quarter’s My Bugaboo column will feature details on the CRE to infection preventionists. Obviously, the impact of microbial family of bacteria. The intention is to convey succinct information disease cannot be overstated. Traditionally the teaching of to busy infection preventionists for common etiologic agents of microbiology has been based mostly on memorization of facts healthcare-associated infections. 30 | SUMMER 2013 | Prevention MULTIDRUG-resistant GRAM-NEGative ROD ALert: After initial outbreaks in the northeastern U.S., CRE bacteria have THE CDC SAYS WE MUST ACT NOW! emerged in multiple species of Gram-negative rods worldwide. They Carbapenem-resistant Enterobacteriaceae (CRE) infections come have created significant clinical challenges for clinicians because they from bacteria normally found in a healthy person’s digestive tract. are not consistently identified by routine screening methods and are CRE bacteria have been associated with the use of medical devices highly drug-resistant, resulting in delays in effective treatment and a such as: intravenous catheters, ventilators, urinary catheters, and high rate of clinical failures.
    [Show full text]
  • The Characteristics of Gut Microbiota and Commensal Enterobacteriaceae Isolates in Tree Shrew
    Gu et al. BMC Microbiology (2019) 19:203 https://doi.org/10.1186/s12866-019-1581-9 RESEARCHARTICLE Open Access The characteristics of gut microbiota and commensal Enterobacteriaceae isolates in tree shrew (Tupaia belangeri) Wenpeng Gu1,2, Pinfen Tong1, Chenxiu Liu1, Wenguang Wang1, Caixia Lu1, Yuanyuan Han1, Xiaomei Sun1, De Xuan Kuang1,NaLi1 and Jiejie Dai1* Abstract Background: Tree shrew is a novel laboratory animal with specific characters for human disease researches in recent years. However, little is known about its characteristics of gut microbial community and intestinal commensal bacteria. In this study, 16S rRNA sequencing method was used to illustrate the gut microbiota structure and commensal Enterobacteriaceae bacteria were isolated to demonstrate their features. Results: The results showed Epsilonbacteraeota (30%), Proteobacteria (25%), Firmicutes (19%), Fusobacteria (13%), and Bacteroidetes (8%) were the most abundant phyla in the gut of tree shrew. Campylobacteria, Campylobacterales, Helicobacteraceae and Helicobacter were the predominant abundance for class, order, family and genus levels respectively. The alpha diversity analysis showed statistical significance (P < 0.05) for operational taxonomic units (OTUs), the richness estimates, and diversity indices for age groups of tree shrew. Beta diversity revealed the significant difference (P < 0.05) between age groups, which showed high abundance of Epsilonbacteraeota and Spirochaetes in infant group, Proteobacteria in young group, Fusobacteria in middle group, and Firmicutes in senile group. The diversity of microbial community was increased followed by the aging process of this animal. 16S rRNA gene functional prediction indicated that highly hot spots for infectious diseases, and neurodegenerative diseases in low age group of tree shrew (infant and young).
    [Show full text]
  • MICROBIOLOGY LEGEND CYCLE 33 ORGANISM 1 Proteus Spp
    P.O. Box 131375, Bryanston, 2074 Ground Floor, Block 5 Bryanston Gate, 170 Curzon Road Bryanston, Johannesburg, South Africa 804 Flatrock, Buiten Street, Cape Town, 8001 www.thistle.co.za Tel: +27 (011) 463 3260 Fax: +27 (011) 463 3036 Fax to Email: + 27 (0) 86‐557‐2232 e‐mail : [email protected] Please read this section first The HPCSA and the Med Tech Society have confirmed that this clinical case study, plus your routine review of your EQA reports from Thistle QA, should be documented as a “Journal Club” activity. This means that you must record those attending for CEU purposes. Thistle will not issue a certificate to cover these activities, nor send out “correct” answers to the CEU questions at the end of this case study. The Thistle QA CEU No is: MT-11/00142. Each attendee should claim THREE CEU points for completing this Quality Control Journal Club exercise, and retain a copy of the relevant Thistle QA Participation Certificate as proof of registration on a Thistle QA EQA. MICROBIOLOGY LEGEND CYCLE 33 ORGANISM 1 Proteus spp. Proteus spp. are found in the human GI tract, soil, water, and sewage. They are associated with UTI’s, pneumonia, wound infections, septicemia, and meningitis. P. mirabilis is the most commonly isolated species. The species comprising the genus Proteus are distinguished biochemically from Morganella and Providencia spp. by their production of hydrogen sulphide and lipase, hydrolysis of gelatin and a lack of acid production from mannose. Optimum growth conditions for these bacterial species are obtained at 37°C, which reflects the intestinal niche occupied by many of these bacteria.
    [Show full text]
  • Molecular Detection of Some Virulence Factors of Uropathogenic Proteus Mirabilis
    Bunyan & Albakery (2021): Molecular detection of virulence factors in P mirabilis infection © Annals of Tropical Medicine & Public Health DOI:http://doi.org/10.36295/ASRO.2021.24616 Molecular Detection of Some Virulence Factors of Uropathogenic Proteus mirabilis Ilham A. Bunyan*1, Solav A. Albakery2 1. Dept. of Microbiology, College of Medicine, Babylon/Iraq 2. Hilla University College, Iraq *Corresponding Author E-mail: [email protected] Abstract: In the present study,120 urine samples were collected from patients suffering from urinary tract infection from both sexes and from different ages, during the period from July 2020 to November 2020 from the private laboratories in Hilla, Iraq, to detect Proteus mirablis (P mirabilis)bacteria, and the results of the biochemical tests and Vitek 2 system showed that 36(30%) samples belong to P. mirablis. Some of the virulence factors genes were investigated using Single Polymerase Chain Reaction Technique and they are ureC responsible for production of urease enzyme, hpmA, which is responsible for producing of hemolysin, zapA responsible for production of protease enzyme, rsbA responsible of regulatory of swarming phenomenon, mrp which responsible of mannose-resistant proteus like fimbriae, flaA, responsible for flagella, for the rates of the appearance of these genes were (100%), (100%), (100%), (100%),(80%) and (100%) respectively. Keywords: Health sciences; Virulence factors; Patients DOI: http://doi.org/10.36295/ASRO.2021.24616 Page: 536-545 Volume/Issue: Volume: 24 Issue: 06 Introduction:
    [Show full text]
  • Antibiotic-Resistant Bacteria and Gut Microbiome Communities Associated with Wild-Caught Shrimp from the United States Versus Im
    www.nature.com/scientificreports OPEN Antibiotic‑resistant bacteria and gut microbiome communities associated with wild‑caught shrimp from the United States versus imported farm‑raised retail shrimp Laxmi Sharma1, Ravinder Nagpal1, Charlene R. Jackson2, Dhruv Patel3 & Prashant Singh1* In the United States, farm‑raised shrimp accounts for ~ 80% of the market share. Farmed shrimp are cultivated as monoculture and are susceptible to infections. The aquaculture industry is dependent on the application of antibiotics for disease prevention, resulting in the selection of antibiotic‑ resistant bacteria. We aimed to characterize the prevalence of antibiotic‑resistant bacteria and gut microbiome communities in commercially available shrimp. Thirty‑one raw and cooked shrimp samples were purchased from supermarkets in Florida and Georgia (U.S.) between March–September 2019. The samples were processed for the isolation of antibiotic‑resistant bacteria, and isolates were characterized using an array of molecular and antibiotic susceptibility tests. Aerobic plate counts of the cooked samples (n = 13) varied from < 25 to 6.2 log CFU/g. Isolates obtained (n = 110) were spread across 18 genera, comprised of coliforms and opportunistic pathogens. Interestingly, isolates from cooked shrimp showed higher resistance towards chloramphenicol (18.6%) and tetracycline (20%), while those from raw shrimp exhibited low levels of resistance towards nalidixic acid (10%) and tetracycline (8.2%). Compared to wild‑caught shrimp, the imported farm‑raised shrimp harbored
    [Show full text]
  • Anti-Proteus Vulgaris LPS Antibody (SAB4200850)
    Anti-Proteus vulgaris LPS antibody Mouse monoclonal, Clone P.vul-111 purified from hybridoma cell culture Product Number SAB4200850 Product Description In the Proteus spp. group, P. mirabilis is encountered in Monoclonal Anti-Proteus vulgaris LPS antibody (mouse the community and causes the majority of urinary tract IgM isotype) is derived from the P.vul-111 hybridoma, Proteus spp. infections, whereas P. vulgaris and produced by the fusion of mouse myeloma cells and P. penneri are less common and mainly associated with splenocytes from a mouse immunized with nosocomial none urinary infections.2,4 UV-inactivated P. vulgaris OX19 bacteria (ATCC 6380) as immunogen. The isotype is determined by ELISA P. vulgaris has a number of putative virulence factors, using Mouse Monoclonal Antibody Isotyping Reagents including the secreted hemolytic haemolysin and (Product Number ISO2). The antibody is purified from urease, which has been suggested to contribute to host culture supernatant of hybridoma cells. cell invasion, cytotoxicity, and bacterial ability to invade uroepithelial cells.4 P. vulgaris, P. mirabilis and Monoclonal Anti-Proteus vulgaris LPS specifically P. penneri harbor resistance to -lactam antibiotics as it recognizes P. vulgaris whole extract and P. vulgaris is capable of producing inducible -lactamases that LPS, the antibody has no cross reactivity with whole hydrolyze primary and extended-spectrum penicillins extract of Proteus mirabilis, P. gingivalis, E. coli, and cephalosporins. 5-6 Pseudomonas aeruginosa, Shigella flexneri, Staphylococcus aureus, or Salmonella enterica. The Reagent antibody is recommended to be used in various Supplied as a solution in 0.01 M phosphate buffered immunological techniques, including immunoblot and saline, pH 7.4, containing 15 mM sodium azide as a ELISA.
    [Show full text]